Instrumento Inactivo

Acciones Cascadian Therapeutics Inc (USA)

Acciones

Duración

Período

Estilo

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04/01/18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02/01/18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13/12/17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07/12/17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08/11/17

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-1,71 %	103 mil M
REGENERON PHARMACEUTICALS, INC.	+2,49 %	96,73 mil M
ARGENX SE	0,00 %	21,31 mil M
BIONTECH SE	-16,61 %	21,21 mil M
GENMAB A/S	-6,03 %	18,79 mil M
WUXI APPTEC CO., LTD.	-42,14 %	16,37 mil M
BEIGENE, LTD.	-27,40 %	13,68 mil M
NEUROCRINE BIOSCIENCES, INC.	+1,44 %	13,44 mil M
SAREPTA THERAPEUTICS, INC.	+21,29 %	10,98 mil M